Your browser doesn't support javascript.
loading
Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma.
Khan, Muhammad Babar; Ruggieri, Rosamaria; Jamil, Eesha; Tran, Nhan L; Gonzalez, Camila; Mugridge, Nancy; Gao, Steven; MacDiarmid, Jennifer; Brahmbhatt, Himanshu; Sarkaria, Jann N; Boockvar, John; Symons, Marc.
Afiliación
  • Khan MB; The Elmezzi Graduate School of Molecular Medicine, Northwell Health, Manhasset, NY, USA. babarkhan08@gmail.com.
  • Ruggieri R; Karches Center for Oncology, The Institute of Molecular Medicine, The Feinstein Institutes for Medical Research at Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA. babarkhan08@gmail.com.
  • Jamil E; Karches Center for Oncology, The Institute of Molecular Medicine, The Feinstein Institutes for Medical Research at Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.
  • Tran NL; Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.
  • Gonzalez C; Karches Center for Oncology, The Institute of Molecular Medicine, The Feinstein Institutes for Medical Research at Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.
  • Mugridge N; Department of Cancer Biology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Gao S; Karches Center for Oncology, The Institute of Molecular Medicine, The Feinstein Institutes for Medical Research at Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.
  • MacDiarmid J; EnGeneIC Ltd., Sydney, NSW, Australia.
  • Brahmbhatt H; EnGeneIC Ltd., Sydney, NSW, Australia.
  • Sarkaria JN; EnGeneIC Ltd., Sydney, NSW, Australia.
  • Boockvar J; EnGeneIC Ltd., Sydney, NSW, Australia.
  • Symons M; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Mol Med ; 27(1): 28, 2021 03 25.
Article en En | MEDLINE | ID: mdl-33765907
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / MicroARNs / Nanoestructuras / Temozolomida Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / MicroARNs / Nanoestructuras / Temozolomida Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos